In glioblastoma patients pre-RT, mean ± SD of serum Cav1 was 8.07 ± 1.69 that was increased to 9.16 ± 2.45 post-RT, while it was 7.29 ± 0.93 in healthy controls. This evidence concerns the gene CAV1 and glioblastoma.